Parishin C
CAS No. 174972-80-6
Parishin C ( —— )
Catalog No. M20723 CAS No. 174972-80-6
Parishin C is a phenolic glycoside and a major component of G. elata have antioxidant property.
Purity : >98% (HPLC)
Size | Price / USD | Stock | Quantity |
5MG | 107 | In Stock |
|
10MG | 159 | In Stock |
|
25MG | 266 | In Stock |
|
50MG | 393 | In Stock |
|
100MG | Get Quote | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameParishin C
-
NoteResearch use only not for human use.
-
Brief DescriptionParishin C is a phenolic glycoside and a major component of G. elata have antioxidant property.
-
DescriptionParishin C is a phenolic glycoside and a major component of G. elata have antioxidant property.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number174972-80-6
-
Formula Weight728.6
-
Molecular FormulaC32H40O19
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESOC[C@H]1O[C@@H](Oc2ccc(COC(=O)CC(O)(CC(=O)OCc3ccc(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)cc3)C(O)=O)cc2)[C@H](O)[C@@H](O)[C@@H]1O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
CAY10781
CAY10781 is an inhibitor of the protein-protein interaction between neuropilin-1 (NRP-1) and VEGF-A.1It inhibits the interaction by 43% when used at a concentration of 12.5 μM. CAY10781 also inhibits VEGF-A-induced phosphorylation of VEGFR2 in catecholamine A-differentiated (CAD) cells when used at the same concentration.
-
DL-Arabinose
D-Arabinose also known as (+/-)-arabinose or aloe sugar belongs to the class of organic compounds known as pentoses. D-Arabinose has been primarily detected in feces.
-
WEHL-04
WEHL-04 is an intermediate used to prepare (isoquinolinylsulfonyl)benzoic acids as inhibitors of type 5 71-β-hydroxysteroid dehydrogenase AKR1C3. It is also used in the synthesis of 2-aminooctahydrocyclopentalene-3a-carboxamides as potent CCR2 antagonists.